Connect cost, quality and outcomes in physician preference decisions

Use clinical integration and value analysis support to strengthen governance, sourcing and decision-making.

111-Clinical-Integration-&-Value-Analysis.jpg

Value analysis creates more value when it goes beyond price

Healthcare organizations need a stronger way to connect financial discipline with clinical insight. Vizient’s Clinical Integration & Value Analysis support helps teams align cost, quality and outcomes across physician preference item decisions rather than relying on spend data. The result is a governance and sourcing model built to support continuous improvement rather than one-off price conversations.

At a glance

The scale and cost of preference card inaccuracy

Cost reduction potential, performance attributes, and integration inputs strengthen high-performance value analysis.

5-10%

The average supply cost reduction with advanced value analysis programs

5

Critical attributes highlighted in the source performance framework

4

Core integration inputs: stakeholder alignment, cost and utilization data, clinical evidence and standardized decisions

Assess the current model and build the right next-state design

Maturity and design

Assess the current model and build the right next-state design

CIVA starts with assessment and gap analysis, so organizations can understand how mature their current value analysis model really is. That foundation makes it easier to design a program structure that fits the organization rather than copying someone else’s template. It gives the work a more realistic starting point.

Create decision processes that connect cost, quality and outcomes

Governance strength

Create decision processes that connect cost, quality and outcomes

High-performing value analysis depends on governance. Vizient helps organizations build structures that bring multidisciplinary stakeholders, evidence, and performance data into a more standardized decision-making process. That raises the quality of sourcing decisions and helps them last.

Move from price-only analysis to a broader performance model

Continuous improvement

Move from price-only analysis to a broader performance model

The source makes the shift explicit: Advanced value analysis operates across price, efficiency, use and total cost of care. Vizient helps teams move toward that higher-performance model with planning, education and implementation support. This expands the work from tactical review into strategic clinical supply integration.

Transform value analysis

Evolve value analysis into a governance-driven model that links clinical evidence, utilization, and sourcing decisions.

We begin with a comprehensive maturity and gap analysis to establish a clear baseline. This ensures our strategy aligns with your actual program readiness, eliminating assumptions and accelerating your path to performance improvement.

We focus our recommendations on building robust governance structures. This approach empowers your organization to make confident, data-driven decisions long after the initial project concludes, ensuring sustained success.

We treat multidisciplinary alignment as a core requirement, not an optional input. By uniting clinical and operational stakeholders, we ensure your value analysis program drives systemwide consensus and actionable results.

We ground your sourcing decisions in hard data. By leveraging clinical studies, utilization patterns, and outcomes data, we empower your organization to make defensible, high-value choices that improve patient care.

We expand value analysis far beyond unit price. Our model integrates efficiency, product utilization, and total cost of care to deliver comprehensive financial and clinical improvements across your system.

We design your program structure to drive sustained performance improvement over time. This continuous evolution ensures your value analysis capabilities adapt to new challenges and consistently multiply your results.

Talk with our team

Discuss where your value analysis model needs to mature

Connect with our experts to evaluate current-state maturity, governance needs and physician preference item decision processes.